Shilpa Medicare ki Jadcherla Unit 4 ko Austria ki AGES se GMP certification mil gaya hai. Ab company apne sterile injections aur tablets ko European markets mein dhada-dhad export kar payegi.
Shilpa Medicare ka bada break-through
Shilpa Medicare Ltd ke liye ek bahut badi news aa rahi hai. Unki Jadcherla, Telangana mein sthit Unit 4 facility ko ab AGES (Austrian Agency for Health and Food Safety) se officially GMP certification mil gaya hai. Ye clearance July 2026 mein hui inspection ke baad mili hai, jo company ke global standards ko validate karta hai.
Business par kya asar padega?
Ye facility ab European Union aur baki global markets mein sterile injections, tablets, aur capsules supply karne ke liye poori tarah ready hai. Is certification ka matlab hai ki company bina kisi rukawat ke apne products export kar sakti hai, jo aane wale quarters mein revenue ke liye ek solid boost sabit ho sakta hai.
Investors ke liye kya zaruri hai?
Dekhiye, pharma sector mein regulatory approvals milna badi baat hai, lekin usse maintain rakhna usse bhi bada challenge hai. Investors ko ab ye track karna chahiye ki company production volume ko kitna jaldi scale up karti hai. Saath hi, global regulators kabhi bhi follow-up check kar sakte hain, toh quality compliance par nazar rakhna bahut zaruri hai.